# Bank of Marin Bancorp: financial statements, quarterly

BMRC · Nasdaq · CIK 1403475 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bmrc.md) · [Financials](/companies/bmrc/financials.md) · [Filings](/companies/bmrc/filings.md) · [Insiders](/companies/bmrc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bmrc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [10.6](/filings/0001403475-23-000058.md) | [11.2](/filings/0001403475-24-000022.md) | [11.5](/filings/0001403475-24-000040.md) | [11.9](/filings/0001403475-24-000040.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.6](/filings/0001403475-24-000053.md) | [(0.2)](/filings/0001403475-24-000022.md) | [1.0](/filings/0001403475-25-000038.md) | [(12.5)](/filings/0001403475-25-000056.md) | [2.4](/filings/0001403475-25-000070.md) | [3.6](/filings/0001403475-25-000038.md) | [1.6](/filings/0001403475-26-000028.md) | [(2.7)](/filings/0001403475-26-000037.md) | [2.1](/filings/0001403475-25-000070.md) | [(17.8)](/filings/0001403475-26-000028.md) | [3.1](/filings/0001403475-26-000037.md) | [3.4](/filings/0001403475-26-000037.md) |
| Net income | $m | [5.3](/filings/0001403475-24-000053.md) | [0.6](/filings/0001403475-24-000022.md) | [2.9](/filings/0001403475-25-000038.md) | [(21.9)](/filings/0001403475-25-000056.md) | [4.6](/filings/0001403475-25-000070.md) | [6.0](/filings/0001403475-25-000038.md) | [4.9](/filings/0001403475-26-000028.md) | [(8.5)](/filings/0001403475-26-000037.md) | [7.5](/filings/0001403475-25-000070.md) | [(39.5)](/filings/0001403475-26-000028.md) | [8.5](/filings/0001403475-26-000037.md) | [9.2](/filings/0001403475-26-000037.md) |
| Diluted EPS | $ per share | [0.33](/filings/0001403475-24-000053.md) | [0.04](/filings/0001403475-24-000022.md) | [0.18](/filings/0001403475-25-000038.md) | [(1.36)](/filings/0001403475-25-000056.md) | [0.28](/filings/0001403475-25-000070.md) | [0.38](/filings/0001403475-25-000038.md) | [0.30](/filings/0001403475-26-000028.md) | [(0.53)](/filings/0001403475-26-000037.md) | [0.47](/filings/0001403475-25-000070.md) | [(2.49)](/filings/0001403475-26-000028.md) | [0.53](/filings/0001403475-26-000037.md) | [0.58](/filings/0001403475-26-000037.md) |
| Basic EPS | $ per share | [0.33](/filings/0001403475-24-000053.md) | [0.04](/filings/0001403475-24-000022.md) | [0.18](/filings/0001403475-25-000038.md) | [(1.36)](/filings/0001403475-25-000056.md) | [0.28](/filings/0001403475-25-000070.md) | [0.38](/filings/0001403475-25-000038.md) | [0.31](/filings/0001403475-26-000028.md) | [(0.53)](/filings/0001403475-26-000037.md) | [0.47](/filings/0001403475-25-000070.md) | [(2.49)](/filings/0001403475-26-000028.md) | [0.53](/filings/0001403475-26-000037.md) | [0.58](/filings/0001403475-26-000037.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [7.2](/filings/0001403475-24-000012.md) | not reported | not reported | not reported | [10.3](/filings/0001403475-25-000026.md) | not reported | not reported | not reported | [35.2](/filings/0001403475-26-000018.md) | not reported | not reported |
| Total assets | $m | [4,036](/filings/0001403475-23-000058.md) | [3,804](/filings/0001403475-25-000026.md) | [3,767](/filings/0001403475-24-000022.md) | [3,695](/filings/0001403475-24-000040.md) | [3,793](/filings/0001403475-24-000053.md) | [3,701](/filings/0001403475-26-000018.md) | [3,784](/filings/0001403475-25-000038.md) | [3,726](/filings/0001403475-25-000056.md) | [3,869](/filings/0001403475-25-000070.md) | [3,905](/filings/0001403475-26-000037.md) | [3,914](/filings/0001403475-26-000028.md) | [3,857](/filings/0001403475-26-000037.md) |
| Total liabilities | $m | [3,617](/filings/0001403475-23-000058.md) | [3,365](/filings/0001403475-25-000026.md) | [3,330](/filings/0001403475-24-000022.md) | [3,260](/filings/0001403475-24-000040.md) | [3,356](/filings/0001403475-24-000053.md) | [3,266](/filings/0001403475-26-000018.md) | [3,345](/filings/0001403475-25-000038.md) | [3,288](/filings/0001403475-25-000056.md) | [3,425](/filings/0001403475-25-000070.md) | [3,510](/filings/0001403475-26-000037.md) | [3,520](/filings/0001403475-26-000028.md) | [3,460](/filings/0001403475-26-000037.md) |
| Shareholders' equity | $m | [419](/filings/0001403475-24-000053.md) | [439](/filings/0001403475-26-000018.md) | [437](/filings/0001403475-25-000056.md) | [435](/filings/0001403475-25-000070.md) | [437](/filings/0001403475-25-000070.md) | [435](/filings/0001403475-26-000037.md) | [440](/filings/0001403475-26-000037.md) | [439](/filings/0001403475-26-000037.md) | [444](/filings/0001403475-25-000070.md) | [395](/filings/0001403475-26-000037.md) | [394](/filings/0001403475-26-000037.md) | [397](/filings/0001403475-26-000037.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.4 d](/filings/0001403475-24-000053.md) | [0.8 d](/filings/0001403475-26-000018.md) | [4.3](/filings/0001403475-25-000038.md) | [3.4 d](/filings/0001403475-25-000056.md) | [9.9 d](/filings/0001403475-25-000070.md) | [10.7 d](/filings/0001403475-26-000018.md) | [4.9](/filings/0001403475-26-000028.md) | [8.0 d](/filings/0001403475-26-000037.md) | [12.5 d](/filings/0001403475-25-000070.md) | [13.6 d](/filings/0001403475-26-000018.md) | [1.1](/filings/0001403475-26-000028.md) | [12.2 d](/filings/0001403475-26-000037.md) |
| Capital expenditure | $m | [(0.1) d](/filings/0001403475-24-000053.md) | [0.0 d](/filings/0001403475-26-000018.md) | [0.2](/filings/0001403475-25-000038.md) | [0.1 d](/filings/0001403475-25-000056.md) | [0.1 d](/filings/0001403475-25-000070.md) | [0.2 d](/filings/0001403475-26-000018.md) | [0.3](/filings/0001403475-26-000028.md) | [1.0 d](/filings/0001403475-26-000037.md) | [0.4 d](/filings/0001403475-25-000070.md) | [0.1 d](/filings/0001403475-26-000018.md) | [0.2](/filings/0001403475-26-000028.md) | [0.3 d](/filings/0001403475-26-000037.md) |
| Dividends paid | $m | [4.0 d](/filings/0001403475-24-000053.md) | [4.0 d](/filings/0001403475-26-000018.md) | [4.0](/filings/0001403475-25-000038.md) | [4.1 d](/filings/0001403475-25-000056.md) | [4.1 d](/filings/0001403475-25-000070.md) | [4.0 d](/filings/0001403475-26-000018.md) | [4.0](/filings/0001403475-26-000028.md) | [4.1 d](/filings/0001403475-26-000037.md) | [4.0 d](/filings/0001403475-25-000070.md) | [4.0 d](/filings/0001403475-26-000018.md) | [4.0](/filings/0001403475-26-000028.md) | [4.0 d](/filings/0001403475-26-000037.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.0](/filings/0001403475-24-000053.md) | [16.1](/filings/0001403475-24-000022.md) | [16.1](/filings/0001403475-25-000038.md) | [16.1](/filings/0001403475-25-000056.md) | [16.1](/filings/0001403475-25-000070.md) | [16.0](/filings/0001403475-25-000038.md) | [16.0](/filings/0001403475-26-000028.md) | [16.0](/filings/0001403475-26-000037.md) | [15.9](/filings/0001403475-25-000070.md) | [15.9](/filings/0001403475-26-000028.md) | [16.0](/filings/0001403475-26-000037.md) | [16.0](/filings/0001403475-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,194,248 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001403475-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.